Thought Leadership

Explore published articles, interviews, and blog posts from leading IP professionals.

Blog | January 17, 2014

EDTX admits plaintiff's EMVR testimony

Fish & Richardson
Read more
Blog | January 15, 2014

180-Day Statute of Limitations Under 35 U.S.C. 154(b)(3) & (4) Applies to Final Patent Term Adjustment Determinations, Although Time Between Allowance and Issuance Should Not Be Excluded

Fish & Richardson
Read more
Blog | January 15, 2014

EDTX allows cost savings approach for royalties, based on cost of entire location network

Fish & Richardson
Read more
Blog | January 13, 2014

SDNY grants SJ of no pre-notice damages where plaintiff failed to plead marking

Fish & Richardson
Read more
Blog | December 24, 2013

SDNY comments on EMVR's application in pharma context

Fish & Richardson
Read more
Blog | December 23, 2013

DUtah Uses Infringer's Profits to Compute Royalty; Comments on Obligation to Award Reasonable Royalty

Fish & Richardson
Read more
Article | December 20, 2013

Timing of PTO Disclosures - A Trap for the Unwary

Pharmaceutical Compliance Monitor

Read more
Article | December 18, 2013

Validity Challenges: District Court v. Patent Office

Law360

Read more
Blog | December 18, 2013

SDNY orders ongoing royalty as percentage of wholesale price

Fish & Richardson

Read more
Blog | November 25, 2013

NDCA precludes lost profits where damage was to plaintiff's related entity, not plaintiff itself

Fish & Richardson
Read more
Blog | November 22, 2013

Update on pleading standards in Hatch-Waxman cases

Fish & Richardson
Read more
Article | November 22, 2013

Hatch-Waxman Developments: Artificial Infringement by Artificial Drugs

Pharmaceutical Compliance Monitor

Read more